vs
Side-by-side financial comparison of FULTON FINANCIAL CORP (FULT) and P3 Health Partners Inc. (PIII). Click either name above to swap in a different company.
P3 Health Partners Inc. is the larger business by last-quarter revenue ($384.8M vs $336.2M, roughly 1.1× FULTON FINANCIAL CORP). FULTON FINANCIAL CORP runs the higher net margin — 28.2% vs -19.6%, a 47.8% gap on every dollar of revenue. On growth, FULTON FINANCIAL CORP posted the faster year-over-year revenue change (4.2% vs 3.8%). Over the past eight quarters, FULTON FINANCIAL CORP's revenue compounded faster (0.2% CAGR vs -0.5%).
Fulton Financial Corporation is an American regional financial services holding company, headquartered in Lancaster, Pennsylvania.
P3 Health Partners Inc. is a population health management and value-based care services firm operating primarily in the United States. It partners with primary care providers and health systems to deliver coordinated, high-quality care for patient populations, especially Medicare Advantage beneficiaries, focusing on improving health outcomes and lowering unnecessary healthcare costs.
FULT vs PIII — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | ||
|---|---|---|
| Revenue | $336.2M | $384.8M |
| Net Profit | $94.8M | $-75.5M |
| Gross Margin | — | — |
| Operating Margin | — | -40.0% |
| Net Margin | 28.2% | -19.6% |
| Revenue YoY | 4.2% | 3.8% |
| Net Profit YoY | 1.9% | -28.8% |
| EPS (diluted) | $0.55 | $-23.08 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $336.2M | — | ||
| Q4 25 | $336.0M | $384.8M | ||
| Q3 25 | $334.6M | $345.3M | ||
| Q2 25 | $324.1M | $355.8M | ||
| Q1 25 | $318.4M | $373.2M | ||
| Q4 24 | $319.6M | $370.7M | ||
| Q3 24 | $317.7M | $362.1M | ||
| Q2 24 | $334.7M | $379.2M |
| Q1 26 | $94.8M | — | ||
| Q4 25 | $99.0M | $-75.5M | ||
| Q3 25 | $100.5M | $-31.6M | ||
| Q2 25 | $99.2M | $-20.4M | ||
| Q1 25 | $93.0M | $-20.5M | ||
| Q4 24 | $68.6M | $-58.6M | ||
| Q3 24 | $63.2M | $-46.5M | ||
| Q2 24 | $95.0M | $-12.0M |
| Q1 26 | — | — | ||
| Q4 25 | 35.7% | -40.0% | ||
| Q3 25 | 38.2% | -12.8% | ||
| Q2 25 | 37.8% | -9.6% | ||
| Q1 25 | 36.1% | -10.2% | ||
| Q4 24 | 27.0% | -37.4% | ||
| Q3 24 | 25.1% | -29.5% | ||
| Q2 24 | 30.8% | -8.3% |
| Q1 26 | 28.2% | — | ||
| Q4 25 | 29.5% | -19.6% | ||
| Q3 25 | 30.0% | -9.1% | ||
| Q2 25 | 30.6% | -5.7% | ||
| Q1 25 | 29.2% | -5.5% | ||
| Q4 24 | 21.5% | -15.8% | ||
| Q3 24 | 19.9% | -12.8% | ||
| Q2 24 | 28.4% | -3.2% |
| Q1 26 | $0.55 | — | ||
| Q4 25 | $0.53 | $-23.08 | ||
| Q3 25 | $0.53 | $-9.67 | ||
| Q2 25 | $0.53 | $-6.23 | ||
| Q1 25 | $0.49 | $-6.28 | ||
| Q4 24 | $0.36 | $-23.13 | ||
| Q3 24 | $0.33 | $-15.70 | ||
| Q2 24 | $0.52 | $-7.37 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | ||
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $25.0M |
| Total DebtLower is stronger | — | $228.4M |
| Stockholders' EquityBook value | $3.5B | $-155.2M |
| Total Assets | $32.2B | $656.6M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | — | $25.0M | ||
| Q3 25 | — | $37.7M | ||
| Q2 25 | — | $38.6M | ||
| Q1 25 | — | $40.1M | ||
| Q4 24 | — | $38.8M | ||
| Q3 24 | — | $63.0M | ||
| Q2 24 | — | $73.1M |
| Q1 26 | — | — | ||
| Q4 25 | — | $228.4M | ||
| Q3 25 | — | $252.8M | ||
| Q2 25 | — | $182.0M | ||
| Q1 25 | — | $171.1M | ||
| Q4 24 | — | $108.9M | ||
| Q3 24 | — | $133.2M | ||
| Q2 24 | — | $133.1M |
| Q1 26 | $3.5B | — | ||
| Q4 25 | $3.5B | $-155.2M | ||
| Q3 25 | $3.4B | $-18.7M | ||
| Q2 25 | $3.3B | $44.5M | ||
| Q1 25 | $3.3B | $63.3M | ||
| Q4 24 | $3.2B | $75.9M | ||
| Q3 24 | $3.2B | $120.5M | ||
| Q2 24 | $3.1B | $166.8M |
| Q1 26 | $32.2B | — | ||
| Q4 25 | $32.1B | $656.6M | ||
| Q3 25 | $32.0B | $683.6M | ||
| Q2 25 | $32.0B | $731.6M | ||
| Q1 25 | $32.1B | $783.9M | ||
| Q4 24 | $32.1B | $783.4M | ||
| Q3 24 | $32.2B | $833.3M | ||
| Q2 24 | $31.8B | $892.8M |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 4.09× | ||
| Q1 25 | — | 2.71× | ||
| Q4 24 | — | 1.43× | ||
| Q3 24 | — | 1.11× | ||
| Q2 24 | — | 0.80× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | ||
|---|---|---|
| Operating Cash FlowLast quarter | — | $-25.7M |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $304.5M | $-25.7M | ||
| Q3 25 | $116.1M | $-15.4M | ||
| Q2 25 | $91.7M | $-16.6M | ||
| Q1 25 | $703.0K | $-33.5M | ||
| Q4 24 | $416.6M | $-57.2M | ||
| Q3 24 | $-22.0M | $-22.6M | ||
| Q2 24 | $157.8M | $-10.2M |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.0% | ||
| Q3 24 | — | 0.0% | ||
| Q2 24 | — | 0.0% |
| Q1 26 | — | — | ||
| Q4 25 | 3.08× | — | ||
| Q3 25 | 1.16× | — | ||
| Q2 25 | 0.92× | — | ||
| Q1 25 | 0.01× | — | ||
| Q4 24 | 6.07× | — | ||
| Q3 24 | -0.35× | — | ||
| Q2 24 | 1.66× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
FULT
Segment breakdown not available.
PIII
| Capitated Revenue | $366.2M | 95% |
| Health Care Patient Service | $18.6M | 5% |
| Health Care Care Coordination Management Fees | $2.7M | 1% |